Apnimed Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/02/2026 16:00

Company Profile

IndustryBiotechnology

SectorHealthcare

ExchangeNASDAQ

Market Capitalization1,001.64 mln

Float20.46 mln

Earnings Date11/11/2026

EPS

5.72

Strong

P / E

3.76

Deeply undervalued

1-Year Forecast

50.33

Transformational upside

Relative Strength

3 / 100

Severely lagging

Debt / Equity

1.15

Elevated leverage

Pre-Tax Margin

-2%

Barely loss-making

Key Fundamentals

EPS5.72

P/E3.76

RPS21.25

ROIC-53.85

ROA-1.02

EBITDA, mln-53.79

EV / EBITDA-21.99

EV / EBIT-21.98

Revenue, mln38.47

EV / Revenue30.75

Quote Details

Last 21.51

Change -1.03 (-4.57%)

Open 22.60

Volume 680,822

Turnover 14,644,481

Average Volume 613,657

Financial Ratios

Pre-Tax Profit Margin-2

Current Ratio0.41

Debt / Equity1.15

Price / Sales20.57

Financial Strength

1-Year Target Price50.33

Short Ratio2.66

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	1.99%	86 / 100
1 Month	-22.71%	9 / 100